| 000 | 00951 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513205837.0 | ||
| 264 | 0 | _c20000412 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0885-3924 | ||
| 024 | 7 |
_a10.1016/s0885-3924(99)00141-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeen, J C | |
| 245 | 0 | 0 |
_aRe: The use of phenobarbitone in the management of agitation and seizures at the end of life. _h[electronic resource] |
| 260 |
_bJournal of pain and symptom management _cFeb 2000 |
||
| 300 |
_a80-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhenobarbital _xtherapeutic use |
| 650 | 0 | 4 |
_aPsychomotor Agitation _xdrug therapy |
| 650 | 0 | 4 |
_aSeizures _xdrug therapy |
| 650 | 0 | 4 | _aTerminal Care |
| 773 | 0 |
_tJournal of pain and symptom management _gvol. 19 _gno. 2 _gp. 80-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0885-3924(99)00141-4 _zAvailable from publisher's website |
| 999 |
_c10719767 _d10719767 |
||